आईएसएसएन: 2167-0420
Biruk Elias and Tesfahun Hailemariam
Background: Implants contraceptive are one of the most effective reversible modern contraceptive methods. Implants can be used by women from menarche to menopause. Many women can safely use implants including lactating mothers, HIV positive women, cigarette smokers of any age, post abortion women, diabetic women, women at risk for cardiovascular disease (including those with high blood pressure), and adolescents.
Methods: A community based cross-sectional study was conducted among married women aged 18-49 years in East Badewacho Woreda, Southern Ethiopia. Multistage sampling technique was used to select a total of 647 study participants. A pre-tested structured questionnaire was used for data gathering. For data entry Epi-info version 3.5.1 was used and bivariate and multivariate logistic regression analyses were performed using SPSS version 16.0 statistical package.
Results: The implant contraceptive prevalence rate among married women is 96(15.1%). Implanon contraceptives were the most frequently used methods 51(53.1%), sino-implanol 29(30.2%) and jadelle 16(16.7%). Multiple logistic regression model revealed that the husband approval (AOR 3.07, 95% CI 1.64-5.74), joint decision (AOR 5.65, 95% CI 2.78-11.51), married women who have income (AOR 2.74, 95% CI 1.26-5.95), joint discussion (AOR 6.53, 95% CI 3.10-13.77). Similarly, age, disscussed with health workers and health development army leaders were significantly associated with the use of implant contraceptives.
Conclusion: Implant contraceptive utilization is high in the woreda as compared to other methods. Joint decision, joint discussion, discussed with health workers and health development army leaders, husband approval of contraceptive use were significantly associated with the use of implant contraceptives. Therefore, woreda health office and concerned bodies be supposed to focus on couple’s communication, male involvement and community conversation with health worker and health development army leaders that could enhance implant contraceptive utilization.